Advanced Search

Journal of Traditional Chinese Medicine >

2023 , Vol. 43 >Issue 4: 780 - 786

DOI: https://doi.org/10.19852/j.cnki.jtcm.20230608.002

Effect of catgut embedding at acupoints versus non-acupoints in abdominal obesity: a randomized clinical trial

  • Xinghe ZHANG ,
  • Qifu LI ,
  • Rong YI ,
  • Chonghui XING ,
  • Yuhao JIN ,
  • Jiangqiong MENG ,
  • Jialei FENG ,
  • Siwen ZHAO ,
  • Fanrong LIANG ,
  • Taipin GUO
Expand
  • 1 School of Second Clinical Medicine/The Second Affiliated Hospital, Yunnan University of Chinese Medicine, Kunming 650500, China
    2 Department of Acupuncture and Moxibustion, Kunming Hospital of Traditional Chinese Medicine, Kunming 650200, China
    3 Department of Acupuncture and Moxibustion, the Sports Trauma Specialist Hospital of Yunnan Province, Kunming 650051, China
    4 Institute for History of Medicine and Medical Literature, China Academy of Chinese Medical Sciences, Beijing 100027, China
    5 School of Acupuncture and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China

Received date: 2022-03-08

  Accepted date: 2022-08-18

  Online published: 2023-06-08

Supported by

Yunnan Expert Workstation - Liang Fanrong Station: Study and Transformation of Classical Syndrome Differentiation System on Acupuncture and Moxibustion(202305AF150072);Yunnan Province Ten-thousand Plan: Youth Special - Guo Taipin(YNWR-QNBJ-2019-257);Yunnan Provincial Science Project: Study on the Bidirectional Regulation Mechanism of Central Network of Shu-Mu Catgut Embedding in Abdominal Obesity of Stomach Heat-Spleen Deficiency Type Which based on Multimodal Technique(2017FF117-011);Study on the Central Mechanism of Synergistic Potentiation of Shu-Mu Catgut Embedding in Abdominal Obesity(2019FF002-021);Study on the Brain Network Mechanism of Shu-Mu Catgut Embedding in Abdominal Obesity which based on Multi-Modal Technique(202101AZ070001-096)

Fold

Abstract

OBJECTIVE: To explore the difference of catgut embedding effect between acupoints and non-acupoints in patients with abdominal obesity (AO).

METHODS: In this multicenter, double-blind, randomized controlled trial, all subjects were randomly assigned into the acupoint catgut embedding (ACE) group and control group (catgut embedding at non-acupoints). With a 12-week actual intervention period and a 4-week period of follow-up. Waist circumference (WC), body weight, body mass index (BMI), hip circumference (HC) and appetite were applied and assessed at baseline and after 6, 12 and 16 weeks.

RESULTS: After the total intervention phase (12 weeks), the WC, body weight, BMI, HC and visual analogue scale scores of appetite, decreased significantly in the two groups as compared to the baseline (P < 0.001). Meanwhile, after the 4-week follow-up, the indicators still decreased significantly in the ACE group (P < 0.001). At 12 and 16 weeks, catgut embedding at acupoints showed significantly advantages to non-acupoints in WC and appetite (P < 0.05). No serious adverse events were observed in ACE group and control group.

CONCLUSIONS: Catgut embedding at acupoints and non-acupoints are all effective and safe for AO. ACE can effectively treat AO as expected and deliver lasting results.

Key words： acupoint catgut embedding; non-acupoints; obesity; abdominal; waist circumference; randomized controlled trial

Cite this article

Xinghe ZHANG , Qifu LI , Rong YI , Chonghui XING , Yuhao JIN , Jiangqiong MENG , Jialei FENG , Siwen ZHAO , Fanrong LIANG , Taipin GUO . Effect of catgut embedding at acupoints versus non-acupoints in abdominal obesity: a randomized clinical trial[J]. Journal of Traditional Chinese Medicine, 2023 , 43(4) : 780 -786 . DOI: 10.19852/j.cnki.jtcm.20230608.002

References

1. WHO. Obesity and overweight, 2021-06-09, cited at 2022-05-03. Available from URL: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
2. Collaboration NCDRF. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet 2017; 390: 2627-42.
3. Seidell JC, Halberstadt J. The global burden of obesity and the challenges of prevention. Ann Nutr Metab 2015; 66: 7-12.
4. Afshin A, Forouzanfar MH, Reitsma MB, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 2017; 377: 13-27.
5. Dinsa GD, Goryakin Y, Fumagalli E, Suhrcke M. Obesity and socioeconomic status in developing countries: a systematic review. Obes Rev 2012; 13: 1067-79.
6. Zhang LF, Wang ZW, Wang X, et al. Prevalence of abdominal obesity in china: results from a cross-sectional study of nearly half a million participants. Obesity 2019; 27: 1898-905.
7. Lyu Y, Jiang H, Zhang B, et al. Trend of central obesity prevalence among the farmers in nine provinces (autonomous region) of China and social-demographic difference from 1993 to 2015. Wei Sheng Yan Jiu 2020; 49: 357-73.
8. Hua J, Zhang L, Gao D, et al. Prevalence of overweight and obesity among people aged 18 years and over between 2013 and 2018 in hunan, China. Int J Environ Res Public Health 2020; 17: 4048.
9. Bluher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol 2019; 15: 288-98.
10. Chen J, Chen D, Ren Q, et al. Acupuncture and related techniques for obesity and cardiovascular risk factors: a systematic review and Meta-regression analysis. Acupunct Med 2020; 38: 227-34.
11. Broughton DE, Moley KH. Obesity and female infertility: potential mediators of obesity's impact. Fertil Steril 2017; 107: 840-7.
12. Silvestris E, de Pergola G, Rosania R, Loverro G. Obesity as disruptor of the female fertility. Rep Biol Endocrinol 2018; 16: 22.
13. Estes C, Anstee QM, Arias-Loste MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. J Hepatol 2018; 69: 896-904.
14. Alford S, Patel D, Perakakis N, Mantzoros CS. Obesity as a risk factor for Alzheimer's disease: weighing the evidence. Obes Rev 2018; 19: 269-80.
15. Mokdad AH, Ballestros K, Echko M, et al. The state of US health, 1990-2016: burden of diseases, injuries, and risk factors among US states. JAMA 2018; 319: 1444-72.
16. Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer. Gut 2013; 62: 933-47.
17. Matsuda M, Shimomura I. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes Res Clin Pract 2013; 7: e330-41.
18. Cho JH, Shin CM, Han KD, et al. Abdominal obesity increases risk for esophageal cancer: a nationwide population-based cohort study of South Korea. J Gastroenterol 2020; 55: 307-16.
19. Hidayat K, Du X, Chen G, Shi M, Shi B. Abdominal obesity and lung cancer risk: systematic review and Meta-analysis of prospective studies. Nutrients 2016; 8: 810.
20. Mohammadi H, Ohm J, Discacciati A, et al. Abdominal obesity and the risk of recurrent atherosclerotic cardiovascular disease after myocardial infarction. Eur J Prev Cardiol 2020; 27: 1944-52.
21. Tremmel M, Gerdtham UG, Nilsson PM, Saha S. Economic burden of obesity: a systematic literature review. Int J Environ Res Public Health 2017; 14: 435.
22. Caliendo M, Gehrsitz M. Obesity and the labor market: A fresh look at the weight penalty. Econ Hum Biol 2016; 23: 209-25.
23. Liu B. Non-acupoint effects: based on the analysis of traditional acupuncture-moxibustion theory. Zhong Guo Zhen Jiu 2019; 39: 161-5.
24. Chen IJ, Yeh YH, Hsu CH. Therapeutic effect of acupoint catgut embedding in abdominally obese women: a randomized, double-blind, placebo-controlled study. J Womens Health 2018; 27: 782-90.
25. Sheng J, Jin X, Zhu J, Chen Y, Liu X. The effectiveness of acupoint catgut embedding therapy for abdominal obesity: a systematic review and Meta-analysis. Evid Based Complement Alternat Med 2019; 2019: 9714313.
26. Association CM. Guideline for primary care of obesity: practice version (2019). Zhong Hua Quan Ke Yi Shi Za Zhi 2020; 19: 102-7.
27. Group COW. Guidelines for the prevention and control of overweight and obesity in Chinese adults (excerpt). Acta Nutrimenta Sinica 2004; 26: 1-4.
28. Doucet E, Imbeault P, St-Pierre S, et al. Appetite after weight loss by energy restriction and a low-fat diet-exercise follow-up. Int J Obes Relat Metab Disord 2000; 24: 906-14.
29. Abdi H, Zhao B, Darbandi M, et al. The effects of body acupuncture on obesity: anthropometric parameters, lipid profile, and inflammatory and immunologic markers. Sci World J 2012; 2012: 603539.
30. Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 2009; 41: 1149-60.
31. Al-Khudairy L, Loveman E, Colquitt JL, et al. Diet, physical activity and behavioural interventions for the treatment of overweight or obese adolescents aged 12 to 17 years. Cochrane Database Syst Rev 2017; 6: CD012691.
32. Krentz AJ, Fujioka K, Hompesch M. Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles. Diabetes Obes Metab 2016; 18: 558-70.
33. MacLean PS, Wing RR, Davidson T, et al. NIH working group report: innovative research to improve maintenance of weight loss. Obesity 2015; 23: 7-15.
34. Yu EW, Lee MP, Landon JE, Lindeman KG, Kim SC. Fracture risk after bariatric surgery: roux-en-y gastric bypass versus adjustable gastric banding. J Bone Miner Res 2017; 32: 1229-36.
35. Ren XY. Discussion on the origin and mechanism of acupoint embedding. Zhong Guo Yi Yao Xue Bao 2004; 19: 757-9.
36. Gu TZ, Ji YQ. Beauty premium in China's labor market: is discrimination the main reason? China Econ Rev 2019; 57: 14.
37. Chen CM. Overview of obesity in Mainland China. Obes Rev 2008; 9: 14-21.
38. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International diabetes federation task force on epidemiology and prevention; national heart, lung, and blood Institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 2009; 120: 1640-5.
39. Li Z, Zhou J, Cheng S, et al. Cerebral fractional amplitude of low-frequency fluctuations may predict headache intensity improvement following acupuncture treatment in migraine patients. J Tradit Chin Med 2020; 40: 1041-51.
40. Wang X, Huang M, Yang H, et al. Mast cell degranulation and adenosine release: acupoint specificity for effect of electroacupuncture on pituitrin-induced acute heart bradycardia in rabbits. Evid Based Complement Alternat Med 2020; 2020: 1348914.
41. Xing JJ, Zeng BY, Li J, Zhuang Y, Liang FR. Acupuncture point specificity. Int Rev Neurobiol 2013; 111: 49-65.
42. Zhao L, Chen J, Liu CZ, et al. A review of acupoint specificity research in China: status quo and prospects. Evid Based Complement Alternat Med 2012; 2012: 543943.
43. Wang Z, Fan X, Chen K, Yu X, Gao J. Effects of three kinds of head acupuncture therapies on regulation of brain microenvironment and rehabilitation of nerve function in rats with cerebral palsy. J Tradit Chin Med 2021; 41: 276-83.
44. Lin S, Zhu M, Chen W, et al. Acupuncture stimulation of Yamen (GV 15), Fengfu (GV 16), Baihui (GV 20), Shuigou (GV 26) and Hegu (LI 4) reduces brain microglia activation in a traumatic brain injury rat model. J Tradit Chin Med 2020; 40: 267-74.
Options
Outlines

/

〈 〉